February 6, 2026 · Form 4 insider transaction
Gibson Christopher bought 30,346 shares of Recursion Pharmaceuticals Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 0 days after the transaction.
This RSU vested immediately upon the grant date.